Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Evans C, Crawford B. Patient self-reports in pharmacoeconomic studies. Their use and impact on study validity. Pharmacoeconomics 1999; 15(3):241–156
McLoughlin V, Leatherman S. Quality or financing: what drives design of the health care system? Qual Saf Health Care 2003; 12:136–142
Robertson J, Lang D, Hill S. Use of pharmacoeconomics in prescribing research. Part 1: Costs-moving beyond the acquisition price for drugs. J Clin Pharm Ther 2003; 28(1):73–79
Schramm W, Szucs TD. State-of-the-art principles and practices of medical economics. Haemophilia 1998; 4:491–497 Szucs TD, Offner A, Schramm W. Socioeconomic impact of haemophilia care: results of a pilot study. Haemophilia 1996; 2:211–217
Schramm W. Towards the Best Use of Safe Clotting Factor Concentrates.Hämostaseologie 1996; 16:269–273
Wilkinson RG. Socioeconomic determinants of health: Health inequalities: relative or absolute material standards?. BMJ 1997; 314:591
Xu K, Evans DB, Kawabata K, et al. Household catastrophic health expenditure: a multicoutry analysis. Lancet 2003; 362:111–117
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Verlag Berlin Heidelberg
About this paper
Cite this paper
Mihailov, D., Serban, M., Badeti, R., Tepeneu, P., Schramm, W., Lighezan, D. (2007). Economic Evaluation of Orthopedic and Surgical Interventions in Hemophiliacs - Not Only Direct Medical Costs Matter. In: Scharrer, I., Schramm, W. (eds) 36th Hemophilia Symposium Hamburg 2005. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-36715-4_30
Download citation
DOI: https://doi.org/10.1007/978-3-540-36715-4_30
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-36714-7
Online ISBN: 978-3-540-36715-4
eBook Packages: MedicineMedicine (R0)